Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C200486200 on October 21, 2002

J. Biol. Chem., Vol. 277, Issue 50, 47972-47975, December 13, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/50/47972    most recent
C200486200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, Z.
Right arrow Articles by Kandror, K. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, Z.
Right arrow Articles by Kandror, K. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ACCELERATED PUBLICATION
Translocation of Small Preformed Vesicles Is Responsible for the Insulin Activation of Glucose Transport in Adipose Cells

EVIDENCE FROM THE IN VITRO RECONSTITUTION ASSAY*

Zhao Xu and Konstantin V. KandrorDagger

From the Boston University School of Medicine, Boston, Massachusetts 02118

Received for publication, August 26, 2002, and in revised form, October 18, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Insulin stimulates translocation of the glucose transporter isoform 4 (Glut4) from an intracellular storage compartment to the plasma membrane in fat and skeletal muscle cells. At present, the nature of the Glut4 storage compartment is unclear. According to one model, this compartment represents a population of preformed small vesicles that fuse with the plasma membrane in response to insulin stimulation. Alternatively, Glut4 may be retained in large donor membranes, and insulin stimulates the formation of transport vesicles that deliver Glut4 to the cell surface. Finally, insulin can induce plasma membrane fusion of the preformed vesicles and, also, stimulate the formation of new vesicles. In extracts of fat and skeletal muscle cells, Glut4 is predominantly found in small insulin-sensitive 60-70 S membrane vesicles that may or may not artificially derive from large donor membranes during cell homogenization. Here, we use a cell-free reconstitution assay to demonstrate that small Glut4-containing vesicles are formed from large rapidly sedimenting donor membranes in a cytosol-, ATP-, time-, and temperature-dependent fashion and, therefore, do not represent an artifact of homogenization. Thus, small insulin-responsive vesicles represent the major form of Glut4 storage in the living adipose cell. Fusion of these vesicles with the plasma membrane may be largely responsible for the primary effect of insulin on glucose transport in fat tissue. In addition, our results suggest that insulin may also stimulate the formation of Glut4 vesicles and accelerate Glut4 recycling to the plasma membrane.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Insulin regulates postprandial blood glucose levels by reversible translocation of the glucose transporter isoform 4 (Glut4)1 to the plasma membrane in fat and skeletal muscle cells (1). The molecular mechanism of this process is not completely understood. It is not known, in particular, whether insulin stimulates plasma membrane fusion of the pre-existing Glut4-containing vesicles, formation of new transport vesicles from an intracellular storage compartment, or both.

Previously, we reported that, in extracts of adipose cells, the majority of Glut4 is present in two distinct populations of small membrane vesicles, one of which contains cellugyrin, whereas another lacks this protein (2). Subsequent analysis suggested that cellugyrin-positive vesicles transport Glut4 from early to recycling endosomes, whereas cellugyrin-negative vesicles may represent a specialized insulin-responsive population of vesicles that derive from recycling endosomes (3). These data (see also Refs. 4-6) indicate that insulin-responsive 60-70 S vesicles may represent the major form of Glut4 storage in vivo. It is possible, however, that large tubular membrane structures, such as endosomes, may be artificially shattered during cell homogenization into rather homogeneous vesicular population. Therefore, it is unclear whether the Glut4 storage compartment in the living cell is represented by small vesicles or by large fragile membrane structures. To address this question, we broke rat adipocytes open without homogenization by centrifugation only. We found that endosomes were not visibly affected by homogenization and that the major pool of Glut4 was still compartmentalized in small cellugyrin-positive and -negative vesicles, which, therefore, were not likely to represent an artifact of homogenization (3).

We have now established a cell-free reconstitution assay for cellugyrin-positive and -negative Glut4-containing vesicles, and we show here that these vesicles can be formed in vitro in a physiological process. This result supports our previous conclusion and suggests that small 60-70 S insulin-responsive vesicles and not large donor membranes represent the major form of Glut4 storage in the living adipose cell. In addition, we found that insulin stimulated formation of Glut4 vesicles in vitro by ~50%. Thus, although fusion of the preformed vesicles with the plasma membrane should mainly account for the initial effect of insulin on glucose transport in adipocytes, Glut4 recycling through intracellular compartments may also be expedited by insulin.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Materials-- In the present study we used monoclonal anti-Glut4 antibody 1F8 (7) and rabbit polyclonal antibody against cellugyrin (Ac-CQNVETTEGYQPPPVY-OH) that had been raised and affinity-purified by BioSource International (Camarillo, CA). Dexamethasone, 3-isobutyl-1-methylxanthine, insulin, benzamidine, potassium aspartate, potassium glutamate, potassium gluconate, MOPS, sodium carbonate, magnesium sulfate, glutathione (reduced form), ATP, creatine phosphate, creatine phosphokinase, fetal bovine serum, brefeldin A (BFA), wortmannin, guanosine 5'-(gamma -thio)triphosphate (GTPgamma S) and neomycin were purchased from Sigma. Aprotinin, leupeptin, pepstatin A, and phenylmethylsulfonyl fluoride were obtained from American Bioanalytical (Natick, MA). Calf bovine serum and Dulbecco's modified Eagle's medium (DMEM) were purchased from Invitrogen.

Cell Culture-- Murine 3T3-L1 preadipocytes were cultured, differentiated, and maintained as described previously (8). Briefly, cells were grown in DMEM supplemented with 10% calf bovine serum until confluence. Two days later, the cells were transferred to differentiation medium (DMEM containing 10% fetal bovine serum, 0.5 mM 3-isobutyl-1-methylxanthine, 1 µM dexamethasone, and 1.7 µM insulin). After 48 h, the differentiation medium was replaced with maintenance medium (DMEM supplemented with 10% fetal bovine serum). The maintenance medium was changed every 48 h. The cells were used after 8 days of differentiation.

Preparation of Cytosol from Rat Brain and 3T3-L1 Adipocytes-- Brains were dissected from male Sprague-Dawley rats, thoroughly washed with ice-cold budding buffer (9) (38 mM potassium aspartate, 38 mM potassium glutamate, 38 mM potassium gluconate, 20 mM MOPS, 5 mM sodium carbonate, 2.5 mM magnesium sulfate, 5 mM reduced glutathione, 1 mM phenylmethylsulfonyl fluoride, 1 µM pepstatin, 1 µM aprotinin, 1 µM leupeptin, pH 7.2), and homogenized by 12 strokes with a Potter-Elvehjem Teflon pestle. The homogenate was centrifuged at 16,000 × g for 20 min at 4 °C, and the supernatant was re-centrifuged at 200,000 × g for 1 h at 4 °C. The resulting supernatant (brain cytosol) was aliquoted and stored at -80 °C. Cultured 3T3-L1 adipocytes were washed twice with ice-cold budding buffer and homogenized by 10 strokes in a ball-bearing homogenizer (Isobiotec, Heidelberg, Germany) with a 12-µm clearance. The cytosolic fraction was isolated from the homogenate according to the procedure described above and used fresh.

In Vitro Reconstitution of Glut4 Vesicles-- 3T3-L1 adipocytes were washed and homogenized as described in the previous section. The homogenate was centrifuged at 16,000 × g for 20 min at 4 °C. The pellet (heavy membrane fraction) was washed twice with ice-cold budding buffer and re-suspended in ice-cold budding buffer. In some experiments, the pellet was washed with urea-containing stripping buffer (2.5 M urea, 250 mM sorbitol, 20 mM HEPES, 5 mM magnesium acetate, 150 mM potassium acetate) prior to washes with budding buffer (9). This procedure generally decreased the efficiency of Glut4 vesicle budding but did not qualitatively change the results of the assay. Washed heavy membrane fraction (250 µg per sample) was mixed with cytosol and supplied with an ATP regeneration system (1 mM ATP, 8 mM creatine phosphate, 1.5 unit/ml creatine phosphokinase) in a total volume of 250 µl. Samples were kept on ice for 5 min and transferred to 37 °C for the indicated periods of time. Then, samples were centrifuged for the second time at 16,000 × g for 20 min at 4 °C. The pellets of the second centrifugation (donor fraction) were removed, and supernatants were centrifuged at 200,000 × g for 60 min in a Beckman Type 42.2 Ti rotor to harvest de novo formed small vesicles. This vesicle fraction along with the donor fraction were analyzed by Western blotting.

Sucrose Gradient Centrifugation-- Samples (0.2 ml) were loaded onto a 4.6-ml continuous 10-30% sucrose gradient and centrifuged for 55 min in a Beckman SW-55 Ti rotor at 48,000 rpm. Each gradient was collected into 25 fractions starting from the bottom of the tube.

Gel Electrophoresis, Immunoblotting, and Protein Content-- Proteins were separated in SDS-polyacrylamide gels according to Laemmli (10), but without reducing agents, and were transferred to an Immobilon-P membrane (Millipore) in 25 mM Tris, 192 mM glycine. Following transfer, the membrane was blocked with 10% non-fat dry milk in PBST (phosphate-buffered saline with 0.5% Tween 20) for 1 h at 37 °C. Proteins were visualized with specific antibodies, horseradish peroxidase-conjugated secondary antibodies (Sigma), and an enhanced chemiluminescence substrate kit (PerkinElmer Life Sciences). Protein content was determined with the BCA kit (Pierce) according to manufacturer's instructions.

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

3T3-L1 adipocytes were homogenized in a ball-bearing homogenizer, and the homogenate was centrifuged at 16,000 × g for 20 min. Under these conditions, 27 ± 7% of the total Glut4 was found in the heavy membrane fraction recovered in the pellet, whereas 73 ± 5% of Glut4 was present in the supernatant.2

The heavy membrane fraction includes the plasma membrane (11), endoplasmic reticulum (3, 11), mitochondria (11), Golgi membranes (11, 12), lysosomes,3 and endosomes (3). Numerous studies (see, for example, Refs. 13 and 14) including our own (15) demonstrate that, under basal conditions, there is practically no Glut4 in the plasma membrane. In addition, it was shown by several independent approaches that, upon homogenization of rat adipocytes, the plasma membrane has the right-side-out orientation and, therefore, cannot possibly serve as a donor compartment for the formation of any type of vesicles (12, 16). Although these studies were performed in primary rat adipocytes and not in 3T3-L1 cells, the plasma membrane isolated from primary and cultured adipocytes may have the same topology in vitro. The amount of Glut4 in the endoplasmic reticulum is negligibly small in comparison with its total pool (17). That leaves Golgi apparatus and endosomes as a possible source of Glut4 in the heavy membrane fraction.

This fraction was washed as described under "Experimental Procedures" and incubated at 4 °C or at 37 °C with and without brain cytosol and ATP regeneration system in budding buffer for the indicated periods of time. Heavy membranes were then re-pelleted at 16,000 × g for 20 min (donor fraction), and de novo formed vesicles were collected from the supernatant by centrifugation at 200,000 × g for 60 min. Both donor and vesicle fractions were analyzed by Western blotting (Fig. 1).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   Formation of small Glut4 vesicles in vitro is cytosol (A)-, ATP (B)-, temperature (C)-, and time (C)-dependent. 3T3-L1 adipocytes were incubated in serum-free DMEM overnight, homogenized in a ball-bearing homogenizer, and centrifuged at 16,000 × g for 20 min. The pellet (250 µg) was incubated in the absence and in the presence of rat brain cytosol (2 mg/ml unless indicated otherwise) and an ATP regeneration system for 20 min (or for indicated periods of time) at 4 °C or at 37 °C in a total volume of 250 µl and centrifuged again in the same regime. The pellet of the second centrifugation (Donor Fraction) was removed, and the supernatant was centrifuged at 200,000 × g for 60 min in a Beckman Type 42.2 Ti rotor. The pellet of the high speed centrifugation (Vesicle Fraction) along with donor fraction was analyzed by Western blot with 1F8 antibody and with polyclonal antibody against cellugyrin. Each panel shows a representative result of at least three independent experiments.

We found that both cellugyrin and Glut4 are re-distributed from heavy membranes into the vesicle fraction in a cytosol-, ATP-, time-, and temperature-dependent fashion (Fig. 1). It is seen in Fig. 1A that the amount of Glut4 re-distributed to the vesicle fraction is directly proportional to the concentration of brain cytosol, whereas the amount of cellugyrin in this fraction reaches its maximum at 2 mg/ml cytosol and is not increased any further. Also, the yield of Glut4 in the vesicle fraction is decreased after 20 min of incubation, probably due to fusion of de novo formed vesicles with other membranes present in the reaction mixture. On the contrary, the yield of cellugyrin-containing vesicles steadily increases with time. This suggests that Glut4 and cellugyrin may be localized in different types of vesicle formation, which may be controlled by different molecular mechanisms.

In agreement with this hypothesis, the sedimentational analysis shows that two types of vesicles are formed in vitro. These vesicles exactly correspond to cellugyrin-positive and cellugyrin-negative vesicles present in cell extracts (Fig. 2). Together with our previous results showing that these vesicles do not represent an artifact of cell homogenization (3, 4), these data suggest that small Glut4 vesicles exist in the living adipose cell and represent the major Glut4-storing compartment in vivo. Such a conclusion is consistent with results of immunoelectron microscopy, demonstrating that, in adipocytes, Glut4 resides in small vesicles and short tubules with an average diameter of 50-70 nm (13, 18).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   The sedimentational distribution of small vesicles formed in vitro and in vivo is identical. In vitro formed vesicles (combined from 18 individual assays described in the legend to Fig. 1) were pooled, pelleted at 200,000 × g for 60 min, re-suspended in phosphate-buffered saline, and fractionated in a 10-30% continuous sucrose gradient for 55 min at 48,000 rpm in a Beckman SW-55 rotor at 4 °C. 16,000 × g supernatant from 3T3-L1 adipocytes (0.55 mg) was fractionated in parallel. Each gradient was separated into 25 fractions that were analyzed by Western blotting with 1F8 antibody and with polyclonal antibody against cellugyrin. The arrow indicates the direction of sedimentation. A representative result of three independent experiments is shown.

It is known that vesicle budding requires GTP binding to Arf (19), so that this reaction is often stimulated in vitro by GTPgamma S. Indeed, we have determined that GTPgamma S increases recruitment of the adaptor complex AP1 onto donor membranes (results not shown). This, however, does not significantly change the yield of small vesicles (Fig. 3). We believe therefore that, under our experimental conditions, GTP-bound Arf does not limit the budding reaction. Also, addition of wortmannin does not significantly affect the formation of Glut4- and cellugyrin-containing vesicles in vitro (Fig. 3). BFA demonstrates some inhibitory activity at concentrations that dramatically exceeds its ID50 and even LD50 in vivo (20). Since BFA does not block the formation of Glut4 vesicles in vivo (21), a small inhibitory effect of BFA in vitro may not be specific. Aminoglycoside antibiotics neomycin (Fig. 3) and Geneticin (not shown) significantly inhibit formation of vesicles, suggesting that phospholipase D may be involved in regulation of vesicle budding (see also Ref. 22). In our experiments, the inhibitory effect of aminoglycosides in vitro does not exceed 50%. This may be related to the fact that these compounds not only block vesicle budding, but also inhibit vesicle fusion with endosomes (23), thus maintaining an equilibrium between small vesicles and donor membranes in the reaction mixture.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 3.   Formation of small vesicles in vitro in the presence of inhibitors. In vitro budding assay was performed as described under "Experimental Procedures" in the absence (Control) and presence of wortmannin, GTPgamma S, BFA, or neomycin taken at indicated concentrations. In vitro formed vesicles were analyzed by Western blot with 1F8 antibody (A) and with polyclonal antibody against cellugyrin (B). The figure shows mean values ± S.E. of three independent experiments (wortmannin, GTPgamma S) or a representative result of three independent experiments (BFA, neomycin).

We believe that our data are, in general, consistent with recent results of Lim et al. (9) who studied the formation of Glut4-containing vesicles in vitro using brain cytosol and donor membranes from Myc-Glut4-transfected Chinese hamster ovary cells. In both systems, formation of Glut4 vesicles is inhibited by neomycin, whereas BFA does not have any major effect. Moreover, Lim et al. (9) also found that the yield of Glut4 vesicles formed de novo was decreased after the first 15 min of incubation due to fusion with other membranes present in the reaction mixture. A notable inconsistency in our results is that in their experiments, GTPgamma S powerfully inhibits vesicle budding. At present, the reason for this discrepancy is not clear.

We have determined that adipocyte cytosol can support the formation of small vesicles in vitro to the same extent as brain cytosol that is routinely used in budding assays (Fig. 4). Thus, we decided to explore whether or not insulin administration has any effect on the formation of small vesicles in vitro. Since it is not known whether or not insulin changes the amount of Glut4 and cellugyrin in donor membranes, we figured that the direct comparison of vesicle formation in extracts of insulin-treated and not treated cells would be difficult to interpret. Therefore, we isolated the heavy membrane fraction and the cytosol from basal and insulin-treated adipocytes, and we used these fractions in the budding reaction in different combinations (Fig. 5). We found that insulin, indeed, stimulated the formation of Glut4 vesicles in vitro by ~50%. A similar result was recently reported by Kristiansen and Richter (24) who studied the formation of Glut4 vesicles in the extracts of skeletal muscle cells. This increase, although rather modest in in vitro experiments, may still be indicative of a potentially larger effect in vivo, so that the stimulatory effect of insulin on vesicle budding in the living cell may be more pronounced. This hypothesis is consistent with recent results of Foster et al. (25) who showed, by immunofluorescence microscopy, that insulin accelerates inter-endosomal traffic of Glut4 in the L6 cell line. Thus, the results obtained in vitro with the help of the vesicle reconstitution assay suggest that fusion of small preformed Glut4 vesicles with the plasma membrane may account for the initial stimulation of glucose transport by insulin in adipose cells. In addition, insulin may stimulate the formation of Glut4 vesicles de novo and thus increase the rate of Glut4 recycling through its intracellular compartments to the plasma membrane.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 4.   Adipocyte cytosol supports the formation of small vesicles in vitro. Reconstitution assay was performed in vitro for the indicated periods of time as described in the legend to Fig. 1 in the presence of adipocyte cytosol (AC, 2 mg/ml), brain cytosol (BC, 2 mg/ml), or budding buffer (BB) alone. In vitro formed vesicles were analyzed by Western blot with 1F8 antibody and with polyclonal antibody against cellugyrin.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 5.   The effect of insulin on the formation of small vesicles in vitro. Differentiated 3T3-L1 adipocytes were serum-starved overnight and treated or not treated with insulin (100 nM) for 15 min. The heavy membrane fraction (Donor membranes) and cytosol were prepared from insulin-treated (+) and non-treated (-) adipocytes as described under "Experimental Procedures" and used in reconstitution assays in different combinations. In vitro formed vesicles were analyzed by Western blot with 1F8 antibody and with polyclonal antibody against cellugyrin. A, Western blot of the vesicle fraction obtained in a representative experiment. In the lanes marked BB, cytosol was replaced with budding buffer. B, normalized mean values ± S.E. of three independent experiments. Cytosol from insulin-treated adipocytes significantly increased the formation of small Glut4 vesicles from donor membranes isolated from basal (p < 0.05) and from insulin-treated (p < 0.01) cells. The effect of insulin on the formation of cellugyrin-containing vesicles was not statistically significant.


    FOOTNOTES

* This work was supported by research Grants DK52057 and DK56736 from the National Institutes of Health and by a research grant from the American Diabetes Association (to K. V. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Boston University School of Medicine, Dept. of Biochemistry, K124D, 715 Albany St., Boston, MA 02118. Tel.: 617-638-5049; Fax: 617-638-5339; E-mail: kandror@biochem.bumc.bu.edu.

Published, JBC Papers in Press, October 21, 2002, DOI 10.1074/jbc.C200486200

2 M. Malikova and K. V. Kandror, unpublished results.

3 K. V. Kandror, unpublished data.

    ABBREVIATIONS

The abbreviations used are: Glut4, glucose transporter isoform 4; MOPS, 4-morpholinepropanesulfonic acid; BFA, brefeldin A; GTPgamma S, guanosine 5'-(gamma -thio)triphosphate; DMEM, Dulbecco's modified Eagle's medium.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Bryant, N. J., Govers, R., and James, D. E. (2002) Nat. Rev. Mol. Cell. Biol. 3, 267-277[CrossRef][Medline] [Order article via Infotrieve]
2. Kupriyanova, T. A., and Kandror, K. V. (2000) J. Biol. Chem. 275, 36263-36268[Abstract/Free Full Text]
3. Kupriyanova, T. A., Kandror, V., and Kandror, K. V. (2002) J. Biol. Chem. 277, 9133-9138[Abstract/Free Full Text]
4. Kandror, K. V., Coderre, L., Pushkin, A. V., and Pilch, P. F. (1995) Biochem. J. 307, 383-390
5. Heller-Harrison, R. A., Morin, M., Guilherme, A., and Czech, M. P. (1996) J. Biol. Chem. 271, 10200-10204[Abstract/Free Full Text]
6. Bogan, J. S., McKee, A. E., and Lodish, H. F. (2001) Mol. Cell. Biol. 21, 4785-4806[Abstract/Free Full Text]
7. James, D. E., Brown, R., Navarro, J., and Pilch, P. F. (1988) Nature 333, 183-185[CrossRef][Medline] [Order article via Infotrieve]
8. Stephens, J. M., Lee, J., and Pilch, P. F. (1997) J. Biol. Chem. 272, 971-976[Abstract/Free Full Text]
9. Lim, S.-N., Bonzelius, F., Low, S. H., Wille, H., Weimbs, T., and Herman, G. A. (2001) Mol. Biol. Cell 12, 981-995[Abstract/Free Full Text]
10. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
11. Simpson, I. A., Yver, D. R., Hissin, P. J., Wardzala, L. J., Karnieli, E., Salans, L. B., and Cushman, S. W. (1983) Biochim. Biophys. Acta 763, 393-407[Medline] [Order article via Infotrieve]
12. Hedo, J. A., and Simpson, I. A. (1984) J. Biol. Chem. 259, 11083-11089[Abstract/Free Full Text]
13. Slot, S. W., Geuze, H. J., Gigengack, S., Lienhard, G. E., and James, D. E. (1991) J. Cell Biol. 113, 123-135[Abstract/Free Full Text]
14. Malide, D., Ramm, G., Cushman, S. W., and Slot, J. W. (2000) J. Cell Sci. 113, 4203-4210[Abstract]
15. Kandror, K. V. (1999) J. Biol. Chem. 274, 25210-25217[Abstract/Free Full Text]
16. Jarett, L., and Smith, R. M. (1974) J. Biol. Chem. 249, 7024-7031[Abstract/Free Full Text]
17. Roh, C., Roduit, R., Thorens, B., Fried, S., and Kandror, K. V. (2001) J. Biol. Chem. 276, 35990-35994[Abstract/Free Full Text]
18. Smith, R. M., Charron, M. J., Shah, N., Lodish, H., and Jarett, L. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6893-6897[Abstract/Free Full Text]
19. Chavrier, P., and Goud, B. (1999) Curr. Opin. Cell Biol. 11, 466-475[CrossRef][Medline] [Order article via Infotrieve]
20. Torii, S., Banno, T., Watanabe, T., Ikehara, Y., Murakami, K., and Nakayama, K. (1995) J. Biol. Chem. 270, 11574-11580[Abstract/Free Full Text]
21. Martin, S., Ramm, G., Lyttle, C. T., Meerloo, T., Stoorvogel, W., and James, D. E. (2000) Traffic 1, 652-660[CrossRef][Medline] [Order article via Infotrieve]
22. Emoto, M., Klarlund, J. K., Waters, S. B., Hu, V., Buxton, J. M., Chawla, A., and Czech, M. P. (2000) J. Biol. Chem. 275, 7144-7151[Abstract/Free Full Text]
23. Jones, A. T., and Wessling-Resnick, M. (1998) J. Biol. Chem. 273, 25301-25309[Abstract/Free Full Text]
24. Kristiansen, S., and Richter, E. A. (2002) Am. J. Physiol. 283, E374-E382[Abstract/Free Full Text]
25. Foster, L. J., Li, D., Randhawa, V. K., and Klip, A. (2001) J. Biol. Chem. 276, 44212-44221[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Chakrabarti and K. V. Kandror
FoxO1 Controls Insulin-dependent Adipose Triglyceride Lipase (ATGL) Expression and Lipolysis in Adipocytes
J. Biol. Chem., May 15, 2009; 284(20): 13296 - 13300.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Shi, G. Huang, and K. V. Kandror
Self-assembly of Glut4 Storage Vesicles during Differentiation of 3T3-L1 Adipocytes
J. Biol. Chem., October 31, 2008; 283(44): 30311 - 30321.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. K. Randhawa, S. Ishikura, I. Talior-Volodarsky, A. W. P. Cheng, N. Patel, J. H. Hartwig, and A. Klip
GLUT4 Vesicle Recruitment and Fusion Are Differentially Regulated by Rac, AS160, and Rab8A in Muscle Cells
J. Biol. Chem., October 3, 2008; 283(40): 27208 - 27219.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Chakrabarti, T. Anno, B. D. Manning, Z. Luo, and K. V. Kandror
The Mammalian Target of Rapamycin Complex 1 Regulates Leptin Biosynthesis in Adipocytes at the Level of Translation: The Role of the 5'-Untranslated Region in the Expression of Leptin Messenger Ribonucleic Acid
Mol. Endocrinol., October 1, 2008; 22(10): 2260 - 2267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Shisheva
Phosphoinositides in insulin action on GLUT4 dynamics: not just PtdIns(3,4,5)P3
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E536 - E544.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Xu, S. Yu, C.-H. Hsu, J. Eguchi, and E. D. Rosen
The orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II is a critical regulator of adipogenesis
PNAS, February 19, 2008; 105(7): 2421 - 2426.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Larance, G. Ramm, and D. E. James
The GLUT4 Code
Mol. Endocrinol., February 1, 2008; 22(2): 226 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Shi and K. V. Kandror
The Luminal Vps10p Domain of Sortilin Plays the Predominant Role in Targeting to Insulin-responsive Glut4-containing Vesicles
J. Biol. Chem., March 23, 2007; 282(12): 9008 - 9016.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Yu, J. Cresswell, M. G. Loffler, and J. S. Bogan
The Glucose Transporter 4-regulating Protein TUG Is Essential for Highly Insulin-responsive Glucose Uptake in 3T3-L1 Adipocytes
J. Biol. Chem., March 9, 2007; 282(10): 7710 - 7722.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Eyster, Q. S. Duggins, G. J. Gorbsky, and A. L. Olson
Microtubule Network Is Required for Insulin Signaling through Activation of Akt/Protein Kinase B: EVIDENCE THAT INSULIN STIMULATES VESICLE DOCKING/FUSION BUT NOT INTRACELLULAR MOBILITY
J. Biol. Chem., December 22, 2006; 281(51): 39719 - 39727.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. Xu, G. Huang, and K. V. Kandror
Phosphatidylinositol 4-Kinase Type II{alpha} Is Targeted Specifically to Cellugyrin-Positive Glucose Transporter 4 Vesicles
Mol. Endocrinol., November 1, 2006; 20(11): 2890 - 2897.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
E. Gonzalez and T. E. McGraw
Insulin Signaling Diverges into Akt-dependent and -independent Signals to Regulate the Recruitment/Docking and the Fusion of GLUT4 Vesicles to the Plasma Membrane
Mol. Biol. Cell, October 1, 2006; 17(10): 4484 - 4493.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Mari, P. Monzo, V. Kaddai, F. Keslair, T. Gonzalez, Y. Le Marchand-Brustel, and M. Cormont
The Rab4 effector Rabip4 plays a role in the endocytotic trafficking of Glut 4 in 3T3-L1 adipocytes
J. Cell Sci., April 1, 2006; 119(7): 1297 - 1306.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Bose, A. Guilherme, S. Huang, A. C. Hubbard, C. R. Lane, N. A. Soriano, and M. P. Czech
The v-SNARE Vti1a Regulates Insulin-stimulated Glucose Transport and Acrp30 Secretion in 3T3-L1 Adipocytes
J. Biol. Chem., November 4, 2005; 280(44): 36946 - 36951.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. V. Li and K. V. Kandror
Golgi-Localized, {gamma}-Ear-Containing, Arf-Binding Protein Adaptors Mediate Insulin-Responsive Trafficking of Glucose Transporter 4 in 3T3-L1 Adipocytes
Mol. Endocrinol., August 1, 2005; 19(8): 2145 - 2153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Malikova, J. Shi, and K. V. Kandror
V-type ATPase is involved in biogenesis of GLUT4 vesicles
Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E547 - E552.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. M. Belfort and K. V. Kandror
Cellugyrin and Synaptogyrin Facilitate Targeting of Synaptophysin to a Ubiquitous Synaptic Vesicle-sized Compartment in PC12 Cells
J. Biol. Chem., November 28, 2003; 278(48): 47971 - 47978.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/50/47972    most recent
C200486200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, Z.
Right arrow Articles by Kandror, K. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, Z.
Right arrow Articles by Kandror, K. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement